According to the official website of the World Health Organization on February 15th, the Third Conference of the Parties to the Protocol on the Elimination of Illegal Trade in Tobacco Products (MOP3) has officially concluded. The conference supports the fight against illegal trade in tobacco products that harm health and deprive national governments of tax revenue to support public health initiatives.
Dr. Adriana Blanco Marquizo, head of the Secretariat of the World Health Organization Framework Convention on Tobacco Control, said, "This week's meeting made important decisions on tobacco tracking and tracking systems, and approved a roadmap for evidence-based research on illegal trade."
Dr. Blanco said, "We have also reached an agreement on improving the reporting system used by the contracting parties, which will enhance the quality of data related to the implementation of the protocol and help guide future tobacco control efforts."
The Conference of the Parties to the Protocol is the governing body of the Protocol, which is an international treaty that came into effect in 2018, aimed at taking a series of measures through cooperation between countries to eliminate the illegal trade in tobacco products.
Dr. Blanco said, "This is a global solution to a global problem."
Illegal trade accounts for approximately 11% of global tobacco trade, and eliminating illegal tobacco trade could increase global tax revenue by approximately $47.4 billion annually.
The Third Conference of the Parties to the Protocol on the Elimination of Illegal Trade in Tobacco Products also adopted the Panama Declaration, calling on governments to be vigilant of the ongoing movements of the tobacco industry and its assistants to undermine efforts to eliminate illegal trade in tobacco products.
The Panama Declaration also emphasizes the need for effective action to prevent and combat illegal trade in tobacco products, which requires comprehensive international action and close cooperation in all aspects of illegal trade in tobacco, tobacco products, and tobacco production equipment.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
